Empower Pharmacy Lawsuit: Updated Sept 2026 Claims
Empower Pharmacy Faces Updated Legal Claims as Litigation Continues Into September 2026 Empower Pharmacy, one of the nation's largest compounding pharmacies and a major supplier of compounded semaglutide, tirzepatide, and other peptide-based therapies, is again in the legal spotlight following repo...
Read Full StoryRecent Regulatory News
‘Peptide Party’ in Bengaluru cancelled after FDA raises regulatory, safety concerns
‘Peptide Party’ Event in Bengaluru Called Off Amid FDA Scrutiny A gathering billed as a “Peptide Party” scheduled to take place in Bengaluru has been cancelled after regulatory and safety con...
August 17, 2026: Appeals court finds imported medications have “material, not theoretical” differences
Appeals Court Ruling Reinforces Scrutiny of Imported Medications, Citing "Material, Not Theoretical" Risks A federal appeals court has issued a ruling affirming that medications imported from outside...
RFK Says 14 Banned Peptides Are Coming Back Legal. GHK-Cu Is One of Them, But There's a Catch Nobody's Talking About
RFK Jr. Signals Return of 14 Banned Peptides, But Regulatory Fine Print Raises Questions Health and Human Services Secretary Robert F. Kennedy Jr....
The Best FDA Decision On Peptide Authorization Isn’t Yes Or No
The Best FDA Decision On Peptide Authorization Isn't Yes Or No The Food and Drug Administration's approach to regulating therapeutic peptides has reached an inflection point, and according to a recen...
Phoenix doctor urges caution as FDA moves to regulate popular peptides
Phoenix Doctor Urges Caution as FDA Moves to Regulate Popular Peptides A Phoenix-based physician is warning consumers to exercise caution amid growing regulatory scrutiny of peptide therapies, as the...